{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T14:52:32Z","timestamp":1791211952803,"version":"4.1.0"},"reference-count":121,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,8,11]],"date-time":"2025-08-11T00:00:00Z","timestamp":1754870400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Translational Oncology"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1016\/j.tranon.2025.102505","type":"journal-article","created":{"date-parts":[[2025,8,13]],"date-time":"2025-08-13T21:15:40Z","timestamp":1755119740000},"page":"102505","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["\"A novel approach to understanding the role of TCF3 mutations in childhood B-cell precursor acute lymphoblastic leukemia\""],"prefix":"10.1016","volume":"61","author":[{"given":"Monika","family":"Lejman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aleksandra","family":"Ozyga\u0142a","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8740-9401","authenticated-orcid":false,"given":"Kinga","family":"Wr\u00f3blewska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weronika","family":"Zegard\u0142o","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paulina","family":"Widz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martyna","family":"\u017by\u0142a","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.tranon.2025.102505_bib0001","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/2162-3619-3-16","article-title":"Childhood B-acute lymphoblastic leukemia: a genetic update","volume":"3","author":"Woo","year":"2014","journal-title":"Exp. Hematol. Oncol."},{"issue":"9","key":"10.1016\/j.tranon.2025.102505_bib0002","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1007\/s12098-015-1695-5","article-title":"Leukemias in Children","volume":"82","author":"Seth","year":"2015","journal-title":"Indian J. Pediatr."},{"issue":"5","key":"10.1016\/j.tranon.2025.102505_bib0003","doi-asserted-by":"crossref","first-page":"2755","DOI":"10.3390\/ijms23052755","article-title":"Genetic Biomarkers and Their Clinical Implications in B-Cell Acute Lymphoblastic Leukemia in Children","volume":"23","author":"Lejman","year":"2022","journal-title":"Int. J. Mol. Sci."},{"issue":"2","key":"10.1016\/j.tranon.2025.102505_bib0004","doi-asserted-by":"crossref","first-page":"141","DOI":"10.5603\/AHP.a2022.0007","article-title":"Chemotherapy delays in children with acute lymphoblastic leukemia might influence the outcome of treatment","volume":"53","author":"Pu\u0142a","year":"2022","journal-title":"Acta Haematol. Pol."},{"issue":"1","key":"10.1016\/j.tranon.2025.102505_bib0005","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1002\/gcc.22998","article-title":"Cryptic TCF3 fusions in childhood leukemia: Detection by RNA sequencing","volume":"61","author":"Salim","year":"2022","journal-title":"Genes Chromosomes Cancer"},{"issue":"6","key":"10.1016\/j.tranon.2025.102505_bib0006","article-title":"TCF3-HLF -Positive Acute Lymphoblastic Leukemia Resembling Burkitt Leukemia: Cell Morphologic and Immunophenotypic Findings","author":"Li","year":"2022","journal-title":"J. Co Precis. Oncol."},{"issue":"9","key":"10.1016\/j.tranon.2025.102505_bib0007","doi-asserted-by":"crossref","first-page":"1926","DOI":"10.3390\/jcm10091926","article-title":"Advances in the diagnosis and treatment of pediatric acute lymphoblastic leukemia","volume":"10","author":"Inaba","year":"2021","journal-title":"J. Clin. Med."},{"issue":"1","key":"10.1016\/j.tranon.2025.102505_bib0008","doi-asserted-by":"crossref","first-page":"139","DOI":"10.3390\/cells11010139","article-title":"Insights into modern therapeutic approaches in pediatric acute leukemias","volume":"11","author":"Panuciak","year":"2022","journal-title":"Cells"},{"issue":"1","key":"10.1016\/j.tranon.2025.102505_bib0009","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/s13045-022-01228-0","article-title":"Targeting PARP proteins in acute leukemia: DNA damage response inhibition and therapeutic strategies","volume":"15","author":"Padella","year":"2022","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.tranon.2025.102505_bib0010","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1146\/annurev.immunol.20.092501.162048","article-title":"E protein function in lymphocyte development","volume":"20","author":"Quong","year":"2002","journal-title":"Ann. Rev. Immunol."},{"issue":"1","key":"10.1016\/j.tranon.2025.102505_bib0011","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1111\/j.1600-065X.2010.00957.x","article-title":"E proteins and the regulation of early lymphocyte development","volume":"238","author":"De Pooter","year":"2010","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.tranon.2025.102505_bib0012","doi-asserted-by":"crossref","DOI":"10.1128\/MCB.17.8.4782","article-title":"E2A Deficiency Leads to Abnormalities in \u2423\u25fb T-Cell development and to rapid development of T- Cell lymphomas","volume":"17","author":"Bain","year":"1997","journal-title":"Mol. Cell Biol."},{"issue":"6","key":"10.1016\/j.tranon.2025.102505_bib0013","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1101\/gad.1642408","article-title":"Tcf3 is an integral component of the core regulatory circuitry of embryonic stem cells","volume":"22","author":"Cole","year":"2008","journal-title":"Genes Dev."},{"issue":"2","key":"10.1016\/j.tranon.2025.102505_bib0014","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1038\/s41588-018-0315-5","article-title":"PAX5- driven subtypes of B-progenitor acute lymphoblastic leukemia","volume":"51","author":"Gu","year":"2019","journal-title":"Nat. Genet."},{"key":"10.1016\/j.tranon.2025.102505_bib0015","first-page":"1","article-title":"t(17;19) in Children with Acute Lymphocytic Leukemia: A Report of 3 Cases and a Review of the Literature","volume":"2013","author":"Minson","year":"2013","journal-title":"Case Rep. Hematol."},{"key":"10.1016\/j.tranon.2025.102505_bib0016","series-title":"Encyclopedia of Cancer","article-title":"E2A-PBX1","author":"Hyndman","year":"2008"},{"issue":"40","key":"10.1016\/j.tranon.2025.102505_bib0017","doi-asserted-by":"crossref","first-page":"5708","DOI":"10.1038\/sj.onc.1204592","article-title":"The role of E2A-PBX1 in leukemogenesis","volume":"20","author":"Aspland","year":"2001","journal-title":"Oncogene"},{"issue":"10","key":"10.1016\/j.tranon.2025.102505_bib0018","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1038\/s41408-019-0239-z","article-title":"Characterization of TCF3 rearrangements in pediatric B-lymphoblastic leukemia\/lymphoma by mate-pair sequencing (MPseq) identifies complex genomic rearrangements and a novel TCF3\/TEF gene fusion","volume":"9","author":"Rowsey","year":"2019","journal-title":"Blood Cancer J."},{"key":"10.1016\/j.tranon.2025.102505_bib0019","article-title":"National Library of Medicine","year":"2024","journal-title":"PBX1"},{"issue":"12","key":"10.1016\/j.tranon.2025.102505_bib0020","doi-asserted-by":"crossref","first-page":"1667","DOI":"10.1007\/s00109-021-02139-2","article-title":"PBX1: a key character of the hallmarks of cancer","volume":"99","author":"Veiga","year":"2021","journal-title":"J. Mol. Med."},{"issue":"4","key":"10.1016\/j.tranon.2025.102505_bib0021","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1038\/ng860","article-title":"Pbx1 inactivation disrupts pancreas development and in Ipf1-deficient mice promotes diabetes mellitus","volume":"30","author":"Kim","year":"2002","journal-title":"Nat. Genet."},{"issue":"2","key":"10.1016\/j.tranon.2025.102505_bib0022","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/S0012-1606(02)00038-6","article-title":"Pbx1 regulates nephrogenesis and ureteric branching in the developing kidney","volume":"254","author":"Schnabel","year":"2003","journal-title":"Dev. Biol."},{"key":"10.1016\/j.tranon.2025.102505_bib0023","unstructured":"Zhang LX, Xu L, Zhang CH, Lu YH, Ji TH, Ling LJ. uc.38 induces breast cancer cell apoptosis via PBX."},{"issue":"3","key":"10.1016\/j.tranon.2025.102505_bib0024","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.1182\/blood-2004-03-0802","article-title":"Meis1-mediated apoptosis is caspase dependent and can be suppressed by coexpression of HoxA9 in murine and human cell lines","volume":"105","author":"Wermuth","year":"2005","journal-title":"Blood"},{"issue":"9","key":"10.1016\/j.tranon.2025.102505_bib0025","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1038\/ng.3362","article-title":"Genomics and drug profiling of fatal TCF3-HLF\u2212positive acute lymphoblastic leukemia identifies recurrent mutation patterns and therapeutic options","volume":"47","author":"Fischer","year":"2015","journal-title":"Nat. Genet."},{"issue":"7","key":"10.1016\/j.tranon.2025.102505_bib0026","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.3109\/10428194.2011.565436","article-title":"Prognostic impact of t(1;19)\/TCF3-PBX1 in childhood acute lymphoblastic leukemia in the context of Berlin-Frankfurt-M\u00fcnster-based protocols","volume":"52","author":"Felice","year":"2011","journal-title":"Leuk. Lymphoma"},{"issue":"11","key":"10.1016\/j.tranon.2025.102505_bib0027","doi-asserted-by":"crossref","first-page":"2821","DOI":"10.1080\/10428194.2019.1602267","article-title":"The first case of elderly TCF3-HLF-positive B-cell acute lymphoblastic leukemia","volume":"60","author":"Takeda","year":"2019","journal-title":"Leuk Lymphoma"},{"issue":"2","key":"10.1016\/j.tranon.2025.102505_bib0028","doi-asserted-by":"crossref","first-page":"241","DOI":"10.3324\/haematol.2009.011346","article-title":"Clinical features and prognostic implications of TCF3-PBX1 and ETV6-RUNX1 in adult acute lymphoblastic leukemia","volume":"95","author":"Burmeister","year":"2010","journal-title":"Haematologica"},{"issue":"4","key":"10.1016\/j.tranon.2025.102505_bib0029","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1111\/ijlh.14072","article-title":"TCF3 gene rearrangements in pediatric B-cell acute lymphoblastic leukemia- A single center experience","volume":"45","author":"Zerkalenkova","year":"2023","journal-title":"Int. J. Lab. Hematol."},{"issue":"11","key":"10.1016\/j.tranon.2025.102505_bib0030","doi-asserted-by":"crossref","first-page":"2990","DOI":"10.3324\/haematol.2021.278692","article-title":"Aurora A kinase as a target for therapy in TCF3-HLF rearranged acute lymphoblastic leukemia","volume":"106","author":"Leonard","year":"2021","journal-title":"Haematologica"},{"issue":"1","key":"10.1016\/j.tranon.2025.102505_bib0031","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1186\/s12920-020-0709-y","article-title":"Comprehensive chromosomal aberrations in a case of a patient with TCF3-HLF-positive BCP-ALL","volume":"13","author":"Lejman","year":"2020","journal-title":"BMC. Med. Genomics."},{"issue":"1","key":"10.1016\/j.tranon.2025.102505_bib0032","doi-asserted-by":"crossref","first-page":"118","DOI":"10.3324\/haematol.2016.151035","article-title":"ZNF384 -related fusion genes define a subgroup of childhood B-cell precursor acute lymphoblastic leukemia with a characteristic immunotype","volume":"102","author":"Hirabayashi","year":"2017","journal-title":"Haematologica"},{"key":"10.1016\/j.tranon.2025.102505_bib0033","article-title":"Leukemia With TCF3-ZNF384 rearrangement as a distinct subtype of disease with distinct treatments: perspectives from a case report and literature review","volume":"11","author":"Lin","year":"2021","journal-title":"Front Oncol."},{"issue":"8","key":"10.1016\/j.tranon.2025.102505_bib0034","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0104630","article-title":"A Prospective study of gynecological cancer risk in relation to adiposity factors: cumulative incidence and association with plasma adipokine Levels","volume":"9","author":"Wu","year":"2014","journal-title":"PLoS. One"},{"issue":"9","key":"10.1016\/j.tranon.2025.102505_bib0035","doi-asserted-by":"crossref","first-page":"3667","DOI":"10.1172\/JCI81158","article-title":"Comparative genomics reveals multistep pathogenesis of E2A-PBX1 acute lymphoblastic leukemia","volume":"125","author":"Duque-Afonso","year":"2015","journal-title":"J. Clin. Invest."},{"issue":"4","key":"10.1016\/j.tranon.2025.102505_bib0036","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1007\/s12288-024-01755-5","article-title":"Clinicopathological and immunophenotypic characteristics of Series of ZNF384 Re- arranged acute leukemias","volume":"40","author":"Srinivasan","year":"2024","journal-title":"Indian J. Hematol. Blood Transfus."},{"issue":"3","key":"10.1016\/j.tranon.2025.102505_bib0037","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1182\/blood.V63.3.721.721","article-title":"Pre-B cell leukemia associated with chromosome translocation 1;19","volume":"63","author":"Carroll","year":"1984","journal-title":"Blood."},{"key":"10.1016\/j.tranon.2025.102505_bib0038","first-page":"144","volume":"42","author":"Paulsson","year":"2004"},{"key":"10.1016\/j.tranon.2025.102505_bib0039","first-page":"315","article-title":"Prognostic Impact of t(1;19) in Pediatric B-Cell Acute Lymphoblastic Leukemia (B-ALL) Patients Treated on Contemporary Children;s Oncology Group (COG) Protocols. Oral abstract","volume":"144","author":"Pinchinat","year":"2024","journal-title":"The 66th ASH Annual Meeting Abstracts"},{"issue":"11","key":"10.1016\/j.tranon.2025.102505_bib0040","doi-asserted-by":"crossref","first-page":"2382","DOI":"10.1038\/s41375-024-02395-4","article-title":"Determinants of survival after first relapse of acute lymphoblastic leukemia: a Children's Oncology Group study","volume":"38","author":"Rheingold","year":"2024","journal-title":"Leukemia"},{"issue":"6","key":"10.1016\/j.tranon.2025.102505_bib0041","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1080\/10428194.2024.2320827","article-title":"TCF3::PBX1 fusion pediatric B acute lymphoblastic leukemia in disguise behind the eyes - an unusual clinicopathologic presentation with hyperdiploid clone","volume":"65","author":"Naskar","year":"2024","journal-title":"Leuk. Lymphoma"},{"key":"10.1016\/j.tranon.2025.102505_bib0042","article-title":"Unusual presentation with orbital mass in a child with precursor B-Cell acute lymphoblastic Leukemia","volume":"2019","author":"Sathitsamitphong","year":"2019","journal-title":"Case Rep. Hematol."},{"issue":"1","key":"10.1016\/j.tranon.2025.102505_bib0043","doi-asserted-by":"crossref","first-page":"88","DOI":"10.5301\/ejo.5000647","article-title":"Ophthalmic manifestations in recently diagnosed childhood leukemia","volume":"26","author":"Bitirgen","year":"2016","journal-title":"Eur. J. Ophthalmol."},{"issue":"1","key":"10.1016\/j.tranon.2025.102505_bib0044","doi-asserted-by":"crossref","first-page":"e35","DOI":"10.3324\/haematol.2018.199885","article-title":"B-lymphoblastic lymphoma with TCF3-PBX1 fusion gene","volume":"104","author":"Kubota-Tanaka","year":"2019","journal-title":"Haematologica"},{"issue":"12","key":"10.1016\/j.tranon.2025.102505_bib0045","first-page":"8304","article-title":"Transformation Properties of the E2a-Pbxl Chimeric Oncoprotein: Fusion with E2a Is Essential, but the Pbxl Homeodomain Is Dispensable","volume":"14","author":"Monica","year":"1994","journal-title":"Mol. Cell Biol."},{"issue":"12","key":"10.1016\/j.tranon.2025.102505_bib0046","doi-asserted-by":"crossref","first-page":"1994","DOI":"10.1038\/sj.leu.2401224","article-title":"A multiplex RT- PCR assay for the detection of chimeric transcripts encoded by the risk-stratifying translocations of pediatric acute lymphoblastic leukemia","volume":"12","author":"Scurto","year":"1998","journal-title":"Leukemia"},{"issue":"3","key":"10.1016\/j.tranon.2025.102505_bib0047","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.3390\/ijms25031477","article-title":"CircRNAome of Childhood Acute Lymphoblastic Leukemia: Deciphering Subtype-Specific Expression Profiles and Involvement in TCF3::PBX1 ALL","volume":"25","author":"Gutierrez-Camino","year":"2024","journal-title":"Int. J. Mol. Sci."},{"issue":"3","key":"10.1016\/j.tranon.2025.102505_bib0048","first-page":"422","article-title":"Characterization of the t(17;19) translocation by gene-specific fluorescent in situ hybridization-based cytogenetics and detection of the E2A-HLF fusion transcript and protein in patients' cells","volume":"91","author":"Yeung","year":"2006","journal-title":"Haematologica"},{"issue":"12","key":"10.1016\/j.tranon.2025.102505_bib0049","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1016\/j.cancergen.2012.10.004","article-title":"A novel TCF3-HLF fusion transcript in acute lymphoblastic leukemia with a t(17;19)(q22;p13)","volume":"205","author":"Panagopoulos","year":"2012","journal-title":"Cancer Genet."},{"issue":"1","key":"10.1016\/j.tranon.2025.102505_bib0050","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1038\/s41572-024-00525-x","article-title":"Acute lymphoblastic leukaemia","volume":"10","author":"Pagliaro","year":"2024","journal-title":"Nat. Rev. Dis. Primers."},{"issue":"7","key":"10.1016\/j.tranon.2025.102505_bib0051","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.3324\/haematol.2023.283148","article-title":"TCF3::HLF acute lymphoblastic leukemia: still challenging to cure thirty years later","volume":"108","author":"Tasian","year":"2023","journal-title":"Haematologica"},{"issue":"7","key":"10.1016\/j.tranon.2025.102505_bib0052","doi-asserted-by":"crossref","first-page":"1720","DOI":"10.1038\/s41375-022-01620-2","article-title":"The 5th edition of the world health organization classification of haematolymphoid tumours: lymphoid neoplasms","volume":"36","author":"Alaggio","year":"2022","journal-title":"Leukemia"},{"issue":"2","key":"10.1016\/j.tranon.2025.102505_bib0053","doi-asserted-by":"crossref","first-page":"133","DOI":"10.2217\/epi-2017-0080","article-title":"NGS-based methylation profiling differentiates TCF3-HLF and TCF3-PBX1 positive B-cell acute lymphoblastic leukemia","volume":"10","author":"Kachroo","year":"2018","journal-title":"Epigenomics."},{"key":"10.1016\/j.tranon.2025.102505_bib0054","article-title":"The GeneCards human gene database","year":"2024","journal-title":"TCF3"},{"key":"10.1016\/j.tranon.2025.102505_bib0055","article-title":"National Library of Medicine","year":"2024","journal-title":"Gene and Disease"},{"issue":"5","key":"10.1016\/j.tranon.2025.102505_bib0056","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1530\/REP-21-0463","article-title":"TCF3 regulates human endometrial stromal cell proliferation and migration in RPL","volume":"163","author":"Wei","year":"2022","journal-title":"Reproduction."},{"issue":"11","key":"10.1016\/j.tranon.2025.102505_bib0057","doi-asserted-by":"crossref","first-page":"4437","DOI":"10.1182\/blood-2004-08-2976","article-title":"TEF, an antiapoptotic bZIP transcription factor related to the oncogenic E2A- HLF chimera, inhibits cell growth by down-regulating expression of the common chain of cytokine receptors","volume":"105","author":"Inukai","year":"2005","journal-title":"Blood"},{"issue":"11","key":"10.1016\/j.tranon.2025.102505_bib0058","doi-asserted-by":"crossref","first-page":"3080","DOI":"10.1182\/blood-2011-03-341412","article-title":"Key pathways are frequently mutated in high-risk childhood acute lymphoblastic leukemia: a report from the Children\u2019s Oncology Group","volume":"118","author":"Zhang","year":"2011","journal-title":"Blood"},{"issue":"20","key":"10.1016\/j.tranon.2025.102505_bib0059","doi-asserted-by":"crossref","first-page":"5165","DOI":"10.1182\/bloodadvances.2019001307","article-title":"Landscape of driver mutations and their clinical impacts in pediatric B-cell precursor acute lymphoblastic leukemia","volume":"4","author":"Ueno","year":"2020","journal-title":"Blood Adv."},{"issue":"3","key":"10.1016\/j.tranon.2025.102505_bib0060","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1002\/cam4.221","article-title":"Outcome of TCF3-PBX1 positive pediatric acute lymphoblastic leukemia patients in J apan: a collaborative study of Japan Association of Childhood Leukemia Study (JACLS) and Children\u2019s Cancer and Leukemia Study Group (CCLSG)","volume":"3","author":"Asai","year":"2014","journal-title":"Cancer Med."},{"issue":"11","key":"10.1016\/j.tranon.2025.102505_bib0061","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1002\/ajh.26324","article-title":"The clinical outcomes and genomic landscapes of acute lymphoblastic leukemia patients with E2A-PBX1: A 10-year retrospective study","volume":"96","author":"Zhou","year":"2021","journal-title":"Am. J. Hematol."},{"issue":"9","key":"10.1016\/j.tranon.2025.102505_bib0062","doi-asserted-by":"crossref","first-page":"3385","DOI":"10.1007\/s00277-023-05595-7","article-title":"The advances of E2A-PBX1 fusion in B-cell acute lymphoblastic Leukaemia","volume":"103","author":"Yang","year":"2024","journal-title":"Ann. Hematol."},{"issue":"50","key":"10.1016\/j.tranon.2025.102505_bib0063","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.1814397115","article-title":"Transcriptional landscape of B cell precursor acute lymphoblastic leukemia based on an international study of 1,223 cases","volume":"115","author":"Li","year":"2018","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"11","key":"10.1016\/j.tranon.2025.102505_bib0064","doi-asserted-by":"crossref","first-page":"1989","DOI":"10.1038\/leu.2009.135","article-title":"PAX5 mutations occur frequently in adult B- cell progenitor acute lymphoblastic leukemia and PAX5 haploinsufficiency is associated with BCR-ABL1 and TCF3-PBX1 fusion genes: a GRAALL study","volume":"23","author":"Familiades","year":"2009","journal-title":"Leukemia"},{"key":"10.1016\/j.tranon.2025.102505_bib0065","doi-asserted-by":"crossref","unstructured":"Mullighan CG, Goorha S, Radtke I, Miller CB, Coustan-Smith E, Dalton JD, Girtman K, Mathew S, Ma J, Pounds SB, Su X, Pui CH, Relling MV, Evans WE, Shurtleff SA, Downing JR. Genome-wide analysis of genetic alterations in acute lymphoblastic leukaemia. Nature. 2007 Apr 12;446(7137):758-64. 10.1038\/nature05690. PMID: 17344859.","DOI":"10.1038\/nature05690"},{"issue":"10","key":"10.1016\/j.tranon.2025.102505_bib0066","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1016\/j.cancergen.2015.06.003","article-title":"Frequency of copy number abnormalities in common genes associated with B-cell precursor acute lymphoblastic leukemia cytogenetic subtypes in Brazilian children","volume":"208","author":"Barbosa","year":"2015","journal-title":"Cancer Genet."},{"issue":"1","key":"10.1016\/j.tranon.2025.102505_bib0067","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1186\/s12920-018-0444-9","article-title":"A novel PAX5 rearrangement in TCF3-PBX1 acute lymphoblastic leukemia: a case report","volume":"11","author":"Barbosa","year":"2018","journal-title":"BMC. Med. Genomics."},{"issue":"1","key":"10.1016\/j.tranon.2025.102505_bib0068","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1182\/blood-2008-07-166801","article-title":"A comprehensive analysis of the CDKN2A gene in childhood acute lymphoblastic leukemia reveals genomic deletion, copy number neutral loss of heterozygosity, and association with specific cytogenetic subgroups","volume":"113","author":"Sulong","year":"2009","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.tranon.2025.102505_bib0069","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1111\/j.1365-2141.2011.08824.x","article-title":"Paediatric B-cell precursor acute lymphoblastic leukaemia with t(1;19)(q23;p13): clinical and cytogenetic characteristics of 47 cases from the Nordic countries treated according to NOPHO protocols","volume":"155","author":"Andersen","year":"2011","journal-title":"Br. J. Haematol."},{"issue":"9","key":"10.1016\/j.tranon.2025.102505_bib0070","doi-asserted-by":"crossref","first-page":"2546","DOI":"10.1182\/blood.V85.9.2546.bloodjournal8592546","article-title":"Mutations of the p53 and ras genes in childhood t(1;19)-acute lymphoblastic leukemia","volume":"85","author":"Kawamura","year":"1995","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.tranon.2025.102505_bib0071","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1016\/j.celrep.2018.03.124","article-title":"SETDB2 Links E2A-PBX1 to Cell-Cycle Dysregulation in Acute Leukemia through CDKN2C Repression","volume":"23","author":"Lin","year":"2018","journal-title":"Cell Rep."},{"issue":"2","key":"10.1016\/j.tranon.2025.102505_bib0072","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/S1097-2765(03)00277-6","article-title":"Bmi- 1 Regulation of INK4A-ARF Is a Downstream Requirement for Transformation of Hematopoietic Progenitors by E2a-Pbx1","volume":"12","author":"Smith","year":"2003","journal-title":"Mol. Cell"},{"issue":"4","key":"10.1016\/j.tranon.2025.102505_bib0073","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1002\/cjp2.211","article-title":"CRLF2 and IKZF1 abnormalities in Mexican children with acute lymphoblastic leukemia and recurrent gene fusions: exploring surrogate markers of signaling pathways","volume":"7","author":"Moreno Lorenzana","year":"2021","journal-title":"J. Pathol. Clin. Res."},{"issue":"1","key":"10.1016\/j.tranon.2025.102505_bib0074","first-page":"3976","article-title":"Characterization of RB1 in Pediatric TCF3-PBX1+ acute lymphoblastic leukemia","volume":"130","author":"Barbosa","year":"2017","journal-title":"Blood."},{"issue":"43","key":"10.1016\/j.tranon.2025.102505_bib0075","doi-asserted-by":"crossref","first-page":"6166","DOI":"10.1038\/s41388-021-02012-z","article-title":"Identification of mutations that cooperate with defects in B cell transcription factors to initiate leukemia","volume":"40","author":"Heltemes-Harris","year":"2021","journal-title":"Oncogene"},{"key":"10.1016\/j.tranon.2025.102505_bib0076","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2015\/165238","article-title":"ZNF423 and ZNF521: EBF1 antagonists of potential relevance in B-lymphoid malignancies","volume":"2015","author":"Mesuraca","year":"2015","journal-title":"Biomed. Res. Int."},{"issue":"7","key":"10.1016\/j.tranon.2025.102505_bib0077","doi-asserted-by":"crossref","first-page":"5735","DOI":"10.1007\/s11033-021-06556-x","article-title":"Zinc finger proteins: insights into the transcriptional and post transcriptional regulation of immune response","volume":"48","author":"Rakhra","year":"2021","journal-title":"Mol. Biol. Rep."},{"issue":"5","key":"10.1016\/j.tranon.2025.102505_bib0078","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1182\/bloodadvances.2020001844","article-title":"Genome-wide interference of ZNF423 with B-lineage transcriptional circuitries in acute lymphoblastic leukemia","volume":"5","author":"Iglesias","year":"2021","journal-title":"Blood Adv."},{"issue":"7","key":"10.1016\/j.tranon.2025.102505_bib0079","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1111\/cas.12945","article-title":"Identification of cooperative genes for E2A-PBX1 to develop acute lymphoblastic leukemia","volume":"107","author":"Sera","year":"2016","journal-title":"Cancer Sci."},{"issue":"13","key":"10.1016\/j.tranon.2025.102505_bib0080","doi-asserted-by":"crossref","first-page":"2129","DOI":"10.4161\/cc.10.13.16045","article-title":"Zinc finger protein 521 antagonizes early B-cell factor 1 and modulates the B-lymphoid differentiation of primary hematopoietic progenitors","volume":"10","author":"Mega","year":"2011","journal-title":"Cell Cycle"},{"issue":"23","key":"10.1016\/j.tranon.2025.102505_bib0081","doi-asserted-by":"crossref","first-page":"3185","DOI":"10.1200\/JCO.2011.34.8144","article-title":"Mutations and deletions of the TP53 gene predict nonresponse to treatment and poor outcome in first relapse of childhood acute lymphoblastic leukemia","volume":"29","author":"Hof","year":"2011","journal-title":"J. Clin. Oncol."},{"issue":"3","key":"10.1016\/j.tranon.2025.102505_bib0082","article-title":"Targeting the oncogenic activity of TCF3-HLF in leukemia","volume":"7","author":"Huang","year":"2020","journal-title":"Mol. Cell Oncol."},{"issue":"11","key":"10.1016\/j.tranon.2025.102505_bib0083","doi-asserted-by":"crossref","first-page":"2553","DOI":"10.1007\/s00277-022-04941-5","article-title":"Clonal evolution in adult TCF3::HLF-positive acute lymphoblastic leukemia undergoing stem cell transplantation","volume":"101","author":"Ahmed","year":"2022","journal-title":"Ann. Hematol."},{"issue":"1","key":"10.1016\/j.tranon.2025.102505_bib0084","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1182\/blood.2019002220","article-title":"Therapy-induced mutations drive the genomic landscape of relapsed acute lymphoblastic leukemia","volume":"135","author":"Li","year":"2020","journal-title":"Blood"},{"key":"10.1016\/j.tranon.2025.102505_bib0085","article-title":"Childhood Acute B-lineage lymphoblastic leukemia With CDKN2A\/B Deletion Is a distinct entity with adverse genetic features and poor clinical outcomes","volume":"12","author":"Feng","year":"2022","journal-title":"Front. Oncol."},{"issue":"3","key":"10.1016\/j.tranon.2025.102505_bib0086","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1002\/cam4.87","article-title":"IKZF 1 deletion is associated with a poor outcome in pediatric B-cell precursor acute lymphoblastic leukemia in Japan","volume":"2","author":"Asai","year":"2013","journal-title":"Cancer Med."},{"issue":"5","key":"10.1016\/j.tranon.2025.102505_bib0087","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1056\/NEJMoa0808253","article-title":"Deletion of IKZF1 and prognosis in acute lymphoblastic leukemia","volume":"360","author":"Mullighan","year":"2009","journal-title":"N. Engl. J. Med."},{"issue":"1","key":"10.1016\/j.tranon.2025.102505_bib0088","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1182\/blood-2008-07-166801","article-title":"A comprehensive analysis of the CDKN2A gene in childhood acute lymphoblastic leukemia reveals genomic deletion, copy number neutral loss of heterozygosity, and association with specific cytogenetic subgroups","volume":"113","author":"Sulong","year":"2009","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.tranon.2025.102505_bib0089","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1182\/blood.V76.1.117.117","article-title":"Poor prognosis of children with pre-B acute lymphoblastic leukemia is associated with the t(1;19)(q23;p13): a Pediatric Oncology Group study","volume":"76","author":"Crist","year":"1990","journal-title":"Blood"},{"issue":"8","key":"10.1016\/j.tranon.2025.102505_bib0090","doi-asserted-by":"crossref","first-page":"1380","DOI":"10.1200\/JCO.1990.8.8.1380","article-title":"Cytogenetics of pre-B-cell acute lymphoblastic leukemia with emphasis on prognostic implications of the t(1;19)","volume":"8","author":"Raimondi","year":"1990","journal-title":"J. Clin. Oncol."},{"issue":"5","key":"10.1016\/j.tranon.2025.102505_bib0091","first-page":"363","article-title":"Prognostic significance of the balanced t(1;19) and unbalanced der(19)t(1;19) translocations in acute lymphoblastic leukemia","volume":"6","author":"Secker-Walker","year":"1992","journal-title":"Leukemia"},{"key":"10.1016\/j.tranon.2025.102505_bib0092","doi-asserted-by":"crossref","unstructured":"Yen HJ, Chen SH, Chang TY, Yang CP, Lin DT, Hung IJ, Lin KH, Chen JS, Hsiao CC, et al. Pediatric acute lymphoblastic leukemia with t(1;19)\/TCF3-PBX1 in Taiwan. Pediatric Blood Cancer. 2017;64(10). 10.1002\/pbc.26557. https:\/\/doi.org\/10.1002\/pbc.26557.","DOI":"10.1002\/pbc.26557"},{"issue":"7","key":"10.1016\/j.tranon.2025.102505_bib0093","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.3109\/10428194.2011.565436","article-title":"Prognostic impact of t(1;19)\/TCF3-PBX1 in childhood acute lymphoblastic leukemia in the context of Berlin-Frankfurt-M\u00fcnster-based protocols","volume":"52","author":"Felice","year":"2011","journal-title":"Leuk. Lymphoma"},{"issue":"2","key":"10.1016\/j.tranon.2025.102505_bib0094","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1038\/s41375-020-01072-6","article-title":"Inhibitors targeting Bruton\u2019s tyrosine kinase in cancers: drug development advances","volume":"35","author":"Wen","year":"2021","journal-title":"Leukemia"},{"issue":"8","key":"10.1016\/j.tranon.2025.102505_bib0095","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1007\/s40265-020-01318-8","article-title":"Tirabrutinib: First Approval","volume":"80","author":"Dhillon","year":"2020","journal-title":"Drugs"},{"issue":"5","key":"10.1016\/j.tranon.2025.102505_bib0096","doi-asserted-by":"crossref","first-page":"2400","DOI":"10.3390\/molecules28052400","article-title":"Bruton\u2019s Tyrosine Kinase Inhibitors (BTKIs): Review of preclinical studies and evaluation of clinical Trials","volume":"28","author":"Rozkiewicz","year":"2023","journal-title":"Molecules."},{"issue":"1","key":"10.1016\/j.tranon.2025.102505_bib0097","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1007\/s11523-021-00857-8","article-title":"Tyrosine kinase inhibitors in B-Cell malignancies: their use and differential features","volume":"17","author":"Bruton","year":"2022","journal-title":"Target. Oncol."},{"issue":"29","key":"10.1016\/j.tranon.2025.102505_bib0098","doi-asserted-by":"crossref","first-page":"13075","DOI":"10.1073\/pnas.1004594107","article-title":"The Bruton tyrosine kinase inhibitor PCI-32765 blocks B-cell activation and is efficacious in models of autoimmune disease and B-cell malignancy","volume":"107","author":"Honigberg","year":"2010","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"6","key":"10.1016\/j.tranon.2025.102505_bib0099","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1097\/MBC.0000000000000749","article-title":"Ibrutinib-related bleeding: pathogenesis, clinical implications and management","volume":"29","author":"Aguilar","year":"2018","journal-title":"Blood Coagul. Fibrinol."},{"issue":"23","key":"10.1016\/j.tranon.2025.102505_bib0100","doi-asserted-by":"crossref","first-page":"6937","DOI":"10.1158\/0008-5472.CAN-16-1899","article-title":"E2A-PBX1 remodels oncogenic signaling networks in B-cell precursor acute lymphoid leukemia","volume":"76","author":"Duque-Afonso","year":"2016","journal-title":"Cancer Res."},{"issue":"2","key":"10.1016\/j.tranon.2025.102505_bib0101","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1158\/1078-0432.CCR-07-4175","article-title":"Sprycel for Chronic Myeloid Leukemia and Philadelphia Chromosome\u2013Positive Acute Lymphoblastic Leukemia Resistant to or Intolerant of Imatinib Mesylate","volume":"14","author":"Brave","year":"2008","journal-title":"Clin. Cancer Res."},{"issue":"11","key":"10.1016\/j.tranon.2025.102505_bib0102","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1056\/NEJMoa1403088","article-title":"Targetable kinase-activating Lesions in Ph-like Acute lymphoblastic leukemia","volume":"371","author":"Roberts","year":"2014","journal-title":"N. Engl. J. Med."},{"issue":"17","key":"10.1016\/j.tranon.2025.102505_bib0103","doi-asserted-by":"crossref","first-page":"3288","DOI":"10.1038\/s41388-018-0670-9","article-title":"Wnt5a and ROR1 activate non-canonical Wnt signaling via RhoA in TCF3-PBX1 acute lymphoblastic leukemia and highlight new treatment strategies via Bcl-2 co-targeting","volume":"38","author":"Karvonen","year":"2019","journal-title":"Oncogene"},{"issue":"3","key":"10.1016\/j.tranon.2025.102505_bib0104","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1128\/MCB.17.3.1417","article-title":"Cell Transformation Mediated by Homodimeric E2A-HLF Transcription Factors","volume":"17","author":"Inukai","year":"1997","journal-title":"Mol. Cell Biol."},{"key":"10.1016\/j.tranon.2025.102505_bib0105","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.leukres.2017.05.022","article-title":"Aneuploidy identification in pre-B acute lymphoblastic leukemia patients at diagnosis by Multiplex Ligation-dependent Probe Amplification (MLPA)","volume":"59","author":"V\u00e1zquez-Reyes","year":"2017","journal-title":"Leuk. Res."},{"issue":"6","key":"10.1016\/j.tranon.2025.102505_bib0106","doi-asserted-by":"crossref","first-page":"e244","DOI":"10.3324\/haematol.2018.210104","article-title":"Durable remissions in TCF3-HLF positive acute lymphoblastic leukemia with blinatumomab and stem cell transplantation","volume":"104","author":"Mouttet","year":"2019","journal-title":"Haematologica"},{"issue":"11","key":"10.1016\/j.tranon.2025.102505_bib0107","doi-asserted-by":"crossref","first-page":"5274","DOI":"10.1002\/cam4.2356","article-title":"Resistance of t(17;19)-acute lymphoblastic leukemia cell lines to multiagents in induction therapy","volume":"8","author":"Watanabe","year":"2019","journal-title":"Cancer Med."},{"issue":"6","key":"10.1016\/j.tranon.2025.102505_bib0108","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1016\/j.clml.2021.01.014","article-title":"Successful Treatment of TCF3-HLF-positive Childhood B-ALL with chimeric antigen receptor T-Cell Therapy","volume":"21","author":"Wang","year":"2021","journal-title":"Clin. Lymphoma Myeloma Leuk."},{"issue":"14","key":"10.1016\/j.tranon.2025.102505_bib0109","doi-asserted-by":"crossref","first-page":"2173","DOI":"10.1182\/blood.2021012727","article-title":"Impact of high- risk cytogenetics on outcomes for children and young adults receiving CD19-directed CAR T-cell therapy","volume":"139","author":"Leahy","year":"2022","journal-title":"Blood"},{"issue":"5","key":"10.1016\/j.tranon.2025.102505_bib0110","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1056\/NEJMoa1709919","article-title":"Long- Term Follow-up of CD19 CAR Therapy in Acute Lymphoblastic Leukemia","volume":"378","author":"Park","year":"2018","journal-title":"N. Engl. J. Med."},{"issue":"4","key":"10.1016\/j.tranon.2025.102505_bib0111","doi-asserted-by":"crossref","first-page":"2150","DOI":"10.3390\/ijms22042150","article-title":"A Review of Clinical Outcomes of CAR T-Cell Therapies for B-Acute Lymphoblastic Leukemia","volume":"22","author":"Martino","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"25","key":"10.1016\/j.tranon.2025.102505_bib0112","doi-asserted-by":"crossref","first-page":"3322","DOI":"10.1182\/blood-2017-02-769208","article-title":"Intent-to-treat leukemia remission by CD19 CAR T cells of defined formulation and dose in children and young adults","volume":"129","author":"Gardner","year":"2017","journal-title":"Blood."},{"key":"10.1016\/j.tranon.2025.102505_bib0113","doi-asserted-by":"crossref","DOI":"10.1007\/s00277-024-05945-z","article-title":"CD19 CAR T-cell therapy in relapsed TCF3-HLF-positive B-cell acute lymphoblastic leukemia","author":"Yao","year":"2024","journal-title":"Ann. Hematol."},{"issue":"5","key":"10.1016\/j.tranon.2025.102505_bib0114","doi-asserted-by":"crossref","DOI":"10.1002\/pbc.28249","article-title":"Psychosocial care for children receiving chimeric antigen receptor (CAR) T-cell therapy","volume":"67","author":"Steineck","year":"2020","journal-title":"Pediatr. Blood Cancer"},{"issue":"3","key":"10.1016\/j.tranon.2025.102505_bib0115","doi-asserted-by":"crossref","first-page":"686","DOI":"10.21037\/tp-20-323","article-title":"The advantage of chimeric antigen receptor T cell therapy in pediatric acute lymphoblastic leukemia with E2A-HLF fusion gene positivity: a case series","volume":"10","author":"Wu","year":"2021","journal-title":"Transl. Pediatr."},{"issue":"1","key":"10.1016\/j.tranon.2025.102505_bib0116","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/s13045-022-01228-0","article-title":"Targeting PARP proteins in acute leukemia: DNA damage response inhibition and therapeutic strategies","volume":"15","author":"Padella","year":"2022","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.tranon.2025.102505_bib0117","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.canlet.2016.11.021","article-title":"ADP-ribose) polymerase inhibitors selectively induce cytotoxicity in TCF3-HLF-positive leukemic cells","volume":"386","author":"Piao","year":"2017","journal-title":"Cancer Lett."},{"key":"10.1016\/j.tranon.2025.102505_bib0118","doi-asserted-by":"crossref","DOI":"10.3324\/haematol.2023.283928","article-title":"Proteogenomic profiling uncovers differential therapeutic vulnerabilities between TCF3::PBX1 and TCF3::HLF translocated B-cell acute lymphoblastic leukemia","author":"Blumel","year":"2024","journal-title":"Haematologica [Internet]"},{"issue":"6","key":"10.1016\/j.tranon.2025.102505_bib0119","doi-asserted-by":"crossref","first-page":"3067","DOI":"10.3390\/ijms23063067","article-title":"Resistance Mechanisms in Pediatric B-Cell Acute Lymphoblastic Leukemia","volume":"23","author":"J\u0119draszek","year":"2022","journal-title":"Int. J. Mol. Sci."},{"issue":"7674","key":"10.1016\/j.tranon.2025.102505_bib0120","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1038\/nature24028","article-title":"Discovery of a selective catalytic p300\/CBP inhibitor that targets lineage-specific tumours","volume":"550","author":"Lasko","year":"2017","journal-title":"Nature"},{"issue":"6","key":"10.1016\/j.tranon.2025.102505_bib0121","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1016\/j.ccell.2019.10.004","article-title":"The Leukemogenic TCF3-HLF complex rewires enhancers driving cellular identity and Self-renewal conferring EP300 vulnerability","volume":"36","author":"Huang","year":"2019","journal-title":"Cancer Cell"}],"container-title":["Translational Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1936523325002360?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1936523325002360?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,23]],"date-time":"2025-09-23T04:50:21Z","timestamp":1758603021000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1936523325002360"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11]]},"references-count":121,"alternative-id":["S1936523325002360"],"URL":"https:\/\/doi.org\/10.1016\/j.tranon.2025.102505","relation":{},"ISSN":["1936-5233"],"issn-type":[{"value":"1936-5233","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"\"A novel approach to understanding the role of TCF3 mutations in childhood B-cell precursor acute lymphoblastic leukemia\"","name":"articletitle","label":"Article Title"},{"value":"Translational Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tranon.2025.102505","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"102505"}}